US Patent Issued to MEMORIAL SLOAN-KETTERING CANCER CENTER, EUREKA THERAPEUTICS on May 26 for "Antibodies targeting Fc receptor-like 5 and methods of use" (New York, California Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,636,375, issued on May 26, was assigned to MEMORIAL SLOAN-KETTERING CANCER CENTER (New York) and EUREKA THERAPEUTICS INC. (Emeryville, Calif.).

"Antibodies targeting Fc receptor-like 5 and methods of use" was invented by Renier J. Brentjens (New York), Eric L. Smith (New York) and Cheng Liu (Emeryville, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The presently disclosed subject matter provides fully human antibodies or antigen-binding fragments thereof that bind to FcRL5 and methods of using the same."

The patent was filed on Jan. 7, 2021, under Application No. 17/143,833.

*For further information, including images, charts and tables, please ...